EN
登录

Rice Biotech Launch Pad与Kevin Sheridan扩大外部顾问委员会

Rice Biotech Launch Pad expands external advisory board with Kevin Sheridan

CISION 等信源发布 2023-10-17 20:00

可切换为仅中文


Expert in health care investment banking joins group advising the Houston-based accelerator

医疗保健投资银行专家加入为休斯顿加速器提供咨询的小组

HOUSTON, Oct. 17, 2023 /PRNewswire/ -- Rice University today announced the addition of Kevin Sheridan to its external advisory board for the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university's health and medical technology discoveries into cures. .

2023年10月17日,休斯顿/PRNewswire/-莱斯大学今天宣布将Kevin Sheridan加入其Rice Biotech发射垫的外部咨询委员会,这是一个位于休斯顿的加速器,致力于加速大学健康与医疗技术的翻译发现治愈。 .

Sheridan will be instrumental in providing his counsel in financial expertise to expand the capabilities of the Launch Pad and progress its mission to identify and support highly differentiated projects of the accelerator and drive the growth of Houston as a world-class medical innovation ecosystem.

谢里丹将有助于提供他的财务专业顾问,以扩大发射台的能力,并推进其使命,以确定和支持加速器的高度差异化项目,并推动休斯顿作为世界级医疗创新生态系统的发展。

He has over 25 years of experience in the investment banking industry..

他在投资银行业拥有超过25年的经验。。

'With the formation of the external advisory board earlier this month, the Rice Biotech Launch Pad is well-positioned to stand out among other accelerators and to have a meaningful impact on the biotech industry with the invaluable insights provided by the board,' said Omid Veiseh, associate professor of bioengineering at Rice and faculty director of the accelerator.

Omid Veiseh说:“随着本月早些时候外部咨询委员会的成立,Rice生物技术发射台已经脱颖而出,可以通过董事会提供的宝贵见解对生物技术行业产生有意义的影响。”Rice生物工程副教授和加速器系主任。

'The addition of Kevin reflects our commitment to advancing innovation and achieving the highest standards of excellence. His valuable business acumen greatly enhances our ability to facilitate the successful transition of our faculty's research at Rice into thriving startups.'.

“Kevin的加入反映了我们对推进创新和实现最高卓越标准的承诺。他宝贵的商业敏锐度极大地增强了我们促进我们教师水稻研究成功转型为蓬勃发展的初创企业的能力。

'Our vision for the Rice Biotech Launch Pad is to connect Houston-based researchers with executives across a range of industries,' said Paul Wotton, the accelerator's executive director and chairman. 'Kevin is the next piece of the puzzle to building out the phenomenal group of executives that comprise our external advisory board.

加速器执行董事兼主席保罗·沃顿(Paul Wotton)说:“我们对大米生物技术发射台的愿景是将休斯顿的研究人员与各个行业的高管联系起来。”Kevin是构建构成我们外部顾问委员会的卓越高管群体的下一个难题。

Kevin's background and expertise in advising pharma and biotech companies sets up the accelerator for continued progress in line with our business strategy to expand and advance the university's technologies into therapies and potential cures.'.

Kevin在为制药和生物技术公司提供咨询方面的背景和专业知识为我们的业务战略提供了持续发展的加速器,以扩展和推进大学技术进入治疗和潜在治疗。

Sheridan is the managing director and joint global head of health care investment banking at Jefferies, where he is responsible for 130 health care investment bankers globally while overseeing mergers and acquisitions and advising large-cap pharmaceutical and biotechnology companies in the United States, Europe and Japan.

谢里丹是Jefferies医疗保健投资银行的总经理兼全球联合主管,负责全球130家医疗保健投资经纪人,同时监督兼并和收购,并为美国,欧洲和日本的大型制药和生物技术公司提供咨询服务。

Prior to his current position, he was a managing director at UBS. .

在他现任职位之前,他是UBS的董事。 .

Over the course of his career, Sheridan has led over 200 biotech equity transactions, including initial public offerings and follow-on offerings. He also serves as a board member of ApiJect Systems. He received a bachelor of arts degree from Rutgers University and an MBA from Columbia Business School..

在他职业生涯中,谢里丹领导了200多项生物技术股权交易,包括首次公开发行和后续发行。他还担任ApiJect Systems的董事会成员。他获得了罗格斯大学的艺术学士学位和哥伦比亚商学院的MBA。。

Sheridan is the 12th member of the Launch Pad's external advisory board. The other members are Jason Bock, founder and CEO of CTMC; Albert Cha, managing partner of Frazier Life Sciences; Rima Chakrabarti, partner at KdT Ventures and adjunct professor of neuroscience at the Geisinger Commonwealth School of Medicine; John Flavin, founder and CEO of Portal Innovations, co-founder and chairman of Pyxis Oncology and entrepreneurial advisor of Argonne National Laboratory; Pierre Jacquet, managing director and vice chairman of L.E.K.'s health care consulting practice; Robert Langer, professor at the David H.

谢里丹是发射台外部咨询委员会的第12名成员。其他成员是CTMC的创始人兼首席执行官Jason Bock;Albert Cha,Frazier Life Sciences的管理合作伙伴;Rima Chakrabarti,KdT Ventures的合作伙伴和Geisinger Commonwealth School of Medicine的神经科学副教授;Portal Innovations的创始人兼首席执行官John Flavin,Pyxis肿瘤学联合创始人兼阿贡国家实验室创业顾问;L.E.K.医疗保健咨询实践总经理兼副主席Pierre Jacquet;罗伯特·兰格,David H.教授。

Koch Institute for Integrated Research at the Massachusetts Institute of Technology; Dennis Lee, senior program officer of chemistry, manufacturing and controls at the Bill and Melinda Gates Foundation; Ferran Prat, senior vice president of research administration and industry relations at the MD Anderson Cancer Center; Josh Richardson, managing director and senior investor on the life sciences investigating team at Goldman Sachs; David Schull, president of Russo Partners; and Lisa Wright, president and CEO of Community Health Choice. .

麻省理工学院科赫综合研究所;比尔和梅琳达盖茨基金会化学,制造和控制高级项目官员丹尼斯·李(Dennis Lee);MD安德森癌症中心研究管理和产业关系高级副总裁Ferran Prat;高盛生命科学调查小组总经理兼高级投资者Josh Richardson;Russo合作伙伴总裁David Schull;和社区健康选择总裁兼首席执行官Lisa Wright。 .

About the Rice Biotech Launch Pad

关于大米生物技术发射垫

The Rice Biotech Launch Pad is a Houston-based accelerator focused on expediting the translation of Rice University's health and medical technology discoveries into cures. This initiative is designed to help advance internally discovered platform technologies from concept to clinical studies and commercialization.

Rice Biotech发射台是休斯顿的加速器,专注于加速将莱斯大学的健康和医疗技术发现转化为cures。该计划旨在帮助将内部发现的平台技术从概念推进到临床研究和商业化。

The Rice Biotech Launch Pad will identify and support highly differentiated projects while driving the expansion of Houston as a world-class medical innovation ecosystem. The accelerator will bring together local researchers with a network of industry executives. For more information, please visit https://biotechlaunchpad.rice.edu/. .

大米生物技术发射台将确定和支持高度差异化的项目,同时推动休斯顿作为世界级医疗创新生态系统的扩张。加速器将把当地研究人员与行业高管网络聚集在一起。欲了解更多信息,请访问https://biotechlaunchpad.rice.edu/. .

About Rice University

关于莱斯大学

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation's top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy.

莱斯大学位于休斯顿一个300英亩的森林校园内,一直被美国新闻与世界报道评为全国前20名大学。赖斯高度尊重建筑,商业,继续学习,工程,人文,音乐,自然科学和社会科学学院,是贝克公共政策研究所的所在地。

With 4,552 undergraduates and 3,998 graduate students, Rice's undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 4 for quality of life by the Princeton Review.

赖斯的本科生与教师之比不到6比1,共有4552名本科生和3998名研究生。它的住宅大学系统建立了紧密联系的社区和终身友谊,这就是为什么赖斯在许多种族/阶级互动中排名第一,在普林斯顿评论中排名第四的生活质量的原因之一。

Rice is also rated as a best value among private universities by Kiplinger's Personal Finance..

Kiplinger的个人金融也将大米评为私立大学的最佳价值。。

Media Contacts:

媒体联系人:

Jeff Falk 713-348-6775 [email protected]

杰夫·福尔克713-348-6775[电子邮件保护]

Andrew Bell713-348-6770[email protected]

Andrew Bell713-348-6770[电子邮件保护]

SOURCE Rice University

资源莱斯大学